GENEVA, December 20, 2022– KBI Biopharma, Inc. (KBI), a JSR Life Sciences company, today announced its recently expanded, state-of-the-art Geneva mammalian cell manufacturing facility has obtained a Swissmedic regulatory establishment license. This important designation demonstrates compliance with current Good Manufacturing Practice (cGMP) standards for the production and release of drug substances for clients.

For details, please see the announcement from JSR Life Sciences LLC.
https://news.jsrlifesciences.com/221152-kbi-biopharma-inc-secures-swissmedic-regulatory-establishment-license-for-state-of-the-art-mammalian-cell-manufacturing-facility-in-e